Structure

Physi-Chem Properties

Molecular Weight:  353.16
Volume:  359.329
LogP:  3.798
LogD:  3.366
LogS:  -3.266
# Rotatable Bonds:  2
TPSA:  40.16
# H-Bond Aceptor:  5
# H-Bond Donor:  0
# Rings:  5
# Heavy Atoms:  5

MedChem Properties

QED Drug-Likeness Score:  0.824
Synthetic Accessibility Score:  3.408
Fsp3:  0.429
Lipinski Rule-of-5:  Accepted
Pfizer Rule:  Rejected
GSK Rule:  Accepted
BMS Rule:  0
Golden Triangle Rule:  Accepted
Chelating Alert:  0
PAINS Alert:  0

ADMET Properties (ADMETlab2.0)

ADMET: Absorption

Caco-2 Permeability:  -5.225
MDCK Permeability:  3.007820669154171e-05
Pgp-inhibitor:  0.698
Pgp-substrate:  0.942
Human Intestinal Absorption (HIA):  0.001
20% Bioavailability (F20%):  0.027
30% Bioavailability (F30%):  0.486

ADMET: Distribution

Blood-Brain-Barrier Penetration (BBB):  0.977
Plasma Protein Binding (PPB):  94.1547622680664%
Volume Distribution (VD):  2.04
Pgp-substrate:  2.6867270469665527%

ADMET: Metabolism

CYP1A2-inhibitor:  0.79
CYP1A2-substrate:  0.96
CYP2C19-inhibitor:  0.898
CYP2C19-substrate:  0.924
CYP2C9-inhibitor:  0.076
CYP2C9-substrate:  0.814
CYP2D6-inhibitor:  0.942
CYP2D6-substrate:  0.905
CYP3A4-inhibitor:  0.956
CYP3A4-substrate:  0.913

ADMET: Excretion

Clearance (CL):  14.636
Half-life (T1/2):  0.301

ADMET: Toxicity

hERG Blockers:  0.115
Human Hepatotoxicity (H-HT):  0.169
Drug-inuced Liver Injury (DILI):  0.772
AMES Toxicity:  0.449
Rat Oral Acute Toxicity:  0.428
Maximum Recommended Daily Dose:  0.914
Skin Sensitization:  0.131
Carcinogencity:  0.882
Eye Corrosion:  0.003
Eye Irritation:  0.017
Respiratory Toxicity:  0.944

Download Data

Data Type Select
General Info & Identifiers & Properties  
Structure MOL file  
Source Organisms  
Biological Activities  
Similar NPs/Drugs  

  Natural Product: NPC146288

Natural Product ID:  NPC146288
Common Name*:   Cavidine
IUPAC Name:   n.a.
Synonyms:   (+)-Cavidine; Cavidine
Standard InCHIKey:  JTZZGWPIBBTYNE-FKIZINRSSA-N
Standard InCHI:  InChI=1S/C21H23NO4/c1-12-14-4-5-17-21(26-11-25-17)16(14)10-22-7-6-13-8-18(23-2)19(24-3)9-15(13)20(12)22/h4-5,8-9,12,20H,6-7,10-11H2,1-3H3/t12-,20+/m0/s1
SMILES:  COc1cc2c(cc1OC)CCN1[C@@H]2[C@@H](C)c2c(C1)c1OCOc1cc2
Synthetic Gene Cluster:   n.a.
ChEMBL Identifier:   CHEMBL453544
PubChem CID:   193148
Chemical Classification**:  
  • CHEMONTID:0000000 [Organic compounds]
    • [CHEMONTID:0000279] Alkaloids and derivatives
      • [CHEMONTID:0001909] Protoberberine alkaloids and derivatives

*Note: the InCHIKey will be temporarily assigned as the "Common Name" if no IUPAC name or alternative short name is available.
**Note: the Chemical Classification was calculated by NPClassifier Version 1.5. Reference: PMID:34662515.

  Species Source

Organism ID Organism Name Taxonomy Level Family SuperKingdom Isolation Part Collection Location Collection Time Reference
NPO40821 Corydalis meifolia Species Papaveraceae Eukaryota n.a. n.a. n.a. PMID[6619883]
NPO40821 Corydalis meifolia Species Papaveraceae Eukaryota n.a. n.a. n.a. PMID[6631434]

☑ Note for Reference:
In addition to directly collecting NP source organism data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated them from below databases:
UNPD: Universal Natural Products Database [PMID: 23638153].
StreptomeDB: a database of streptomycetes natural products [PMID: 33051671].
TM-MC: a database of medicinal materials and chemical compounds in Northeast Asian traditional medicine [PMID: 26156871].
TCM@Taiwan: a Traditional Chinese Medicine database [PMID: 21253603].
TCMID: a Traditional Chinese Medicine database [PMID: 29106634].
TCMSP: The traditional Chinese medicine systems pharmacology database and analysis platform [PMID: 24735618].
HerDing: a herb recommendation system to treat diseases using genes and chemicals [PMID: 26980517].
MetaboLights: a metabolomics database [PMID: 27010336].
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  NP Quantity Composition/Concentration

Organism ID NP ID Organism Material Preparation Organism Part NP Quantity (Standard) NP Quantity (Minimum) NP Quantity (Maximum) Quantity Unit Reference

☑ Note for Reference:
In addition to directly collecting NP quantitative data from primary literature (where reference will provided as NCBI PMID or DOI links), NPASS also integrated NP quantitative records for specific NP domains (e.g., NPS from foods or herbs) from domain-specific databases. These databases include:
DUKE: Dr. Duke's Phytochemical and Ethnobotanical Databases.
PHENOL EXPLORER: is the first comprehensive database on polyphenol content in foods [PMID: 24103452], its homepage can be accessed at here.
FooDB: a database of constituents, chemistry and biology of food species [www.foodb.ca].

  Biological Activity

Target ID Target Type Target Name Target Organism Activity Type Activity Relation Value Unit Reference
NPT548 Tissue Ileum Cavia porcellus Inhibition = 84.0 % PMID[546167]
NPT548 Tissue Ileum Cavia porcellus Inhibition = 100.0 % PMID[546167]
NPT548 Tissue Ileum Cavia porcellus IC50 = 0.5 ug.mL-1 PMID[546167]
NPT548 Tissue Ileum Cavia porcellus Activity = 84.0 % PMID[546168]
NPT548 Tissue Ileum Cavia porcellus Activity = 100.0 % PMID[546168]
NPT548 Tissue Ileum Cavia porcellus IC50 = 0.5 ug.mL-1 PMID[546168]

☑ Note for Activity Records:
☉ The quantitative biological activities were primarily integrated from ChEMBL (Version-30) database and were also directly collected from PubMed literature. PubMed PMID was provided as the reference link for each activity record.

  Chemically structural similarity: I. Similar Active Natural Products in NPASS

Top-200 similar NPs were calculated against the active-NP-set (includes 4,3285 NPs with experimentally-derived bioactivity available in NPASS)

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules. Tc lies between [0, 1] where '1' indicates the highest similarity. What is Tanimoto coefficient

●  The left chart: Distribution of similarity level between NPC146288 and all remaining natural products in the NPASS database.
●  The right table: Most similar natural products (Tc>=0.56 or Top200).

Similarity Score Similarity Level Natural Product ID
0.9932 High Similarity NPC216459
0.9932 High Similarity NPC138487
0.9932 High Similarity NPC41178
0.973 High Similarity NPC234392
0.973 High Similarity NPC31311
0.9527 High Similarity NPC210148
0.9527 High Similarity NPC233029
0.9521 High Similarity NPC475959
0.9521 High Similarity NPC7467
0.9477 High Similarity NPC238530
0.9477 High Similarity NPC276944
0.9477 High Similarity NPC232514
0.9452 High Similarity NPC476144
0.9452 High Similarity NPC106295
0.9452 High Similarity NPC16107
0.9452 High Similarity NPC210437
0.9452 High Similarity NPC51957
0.9272 High Similarity NPC93593
0.9216 High Similarity NPC111485
0.9178 High Similarity NPC128019
0.9178 High Similarity NPC476567
0.9178 High Similarity NPC136860
0.9156 High Similarity NPC477559
0.9156 High Similarity NPC160298
0.9156 High Similarity NPC266753
0.9156 High Similarity NPC306902
0.9156 High Similarity NPC232924
0.9119 High Similarity NPC2314
0.9091 High Similarity NPC477080
0.9045 High Similarity NPC24264
0.9045 High Similarity NPC476432
0.9041 High Similarity NPC328750
0.9041 High Similarity NPC188163
0.9041 High Similarity NPC474915
0.9041 High Similarity NPC213206
0.902 High Similarity NPC278799
0.902 High Similarity NPC207757
0.902 High Similarity NPC54379
0.902 High Similarity NPC193949
0.902 High Similarity NPC5238
0.902 High Similarity NPC295691
0.902 High Similarity NPC204828
0.902 High Similarity NPC127674
0.902 High Similarity NPC184026
0.902 High Similarity NPC110416
0.902 High Similarity NPC39701
0.902 High Similarity NPC2413
0.902 High Similarity NPC172765
0.902 High Similarity NPC276588
0.902 High Similarity NPC469817
0.902 High Similarity NPC249797
0.902 High Similarity NPC189266
0.8987 High Similarity NPC247389
0.8981 High Similarity NPC167546
0.8981 High Similarity NPC16805
0.8981 High Similarity NPC225774
0.8981 High Similarity NPC302527
0.8973 High Similarity NPC314682
0.8924 High Similarity NPC219341
0.8896 High Similarity NPC78733
0.8889 High Similarity NPC148898
0.8868 High Similarity NPC210918
0.8868 High Similarity NPC298979
0.8846 High Similarity NPC106786
0.8834 High Similarity NPC148693
0.8834 High Similarity NPC118633
0.8834 High Similarity NPC294790
0.8812 High Similarity NPC241055
0.8808 High Similarity NPC476151
0.8805 High Similarity NPC304659
0.8805 High Similarity NPC86144
0.8797 High Similarity NPC59567
0.8788 High Similarity NPC299990
0.8788 High Similarity NPC73492
0.8767 High Similarity NPC7018
0.8758 High Similarity NPC151895
0.8758 High Similarity NPC192768
0.8758 High Similarity NPC88249
0.8758 High Similarity NPC97221
0.8758 High Similarity NPC220858
0.8742 High Similarity NPC168409
0.8704 High Similarity NPC19520
0.8704 High Similarity NPC149090
0.8701 High Similarity NPC81733
0.8701 High Similarity NPC326316
0.8693 High Similarity NPC477565
0.8693 High Similarity NPC103379
0.8679 High Similarity NPC189470
0.8675 High Similarity NPC185838
0.8654 High Similarity NPC187022
0.8654 High Similarity NPC80129
0.8654 High Similarity NPC76079
0.8642 High Similarity NPC75958
0.8642 High Similarity NPC6152
0.8631 High Similarity NPC477259
0.8631 High Similarity NPC169387
0.8627 High Similarity NPC24233
0.8627 High Similarity NPC147390
0.8627 High Similarity NPC476571
0.8627 High Similarity NPC428
0.8627 High Similarity NPC135538
0.8627 High Similarity NPC246587
0.8606 High Similarity NPC114364
0.8606 High Similarity NPC320223
0.8599 High Similarity NPC247639
0.8599 High Similarity NPC25084
0.8598 High Similarity NPC199465
0.8598 High Similarity NPC229166
0.8598 High Similarity NPC128560
0.8571 High Similarity NPC13916
0.8571 High Similarity NPC264850
0.8571 High Similarity NPC92541
0.8571 High Similarity NPC219162
0.8562 High Similarity NPC321505
0.8562 High Similarity NPC179825
0.8562 High Similarity NPC191376
0.8553 High Similarity NPC215829
0.8553 High Similarity NPC130926
0.8553 High Similarity NPC97072
0.8544 High Similarity NPC476572
0.8535 High Similarity NPC99659
0.8535 High Similarity NPC244112
0.8535 High Similarity NPC325871
0.8529 High Similarity NPC281581
0.8519 High Similarity NPC100566
0.8519 High Similarity NPC57812
0.8519 High Similarity NPC474324
0.8516 High Similarity NPC223125
0.8509 High Similarity NPC24465
0.8509 High Similarity NPC231198
0.8506 High Similarity NPC130941
0.8506 High Similarity NPC37144
0.8506 High Similarity NPC59907
0.8503 High Similarity NPC179704
0.8491 Intermediate Similarity NPC216816
0.8485 Intermediate Similarity NPC187678
0.848 Intermediate Similarity NPC473716
0.848 Intermediate Similarity NPC475597
0.8476 Intermediate Similarity NPC65403
0.8466 Intermediate Similarity NPC82533
0.8466 Intermediate Similarity NPC290759
0.8466 Intermediate Similarity NPC475845
0.8466 Intermediate Similarity NPC266176
0.8466 Intermediate Similarity NPC158148
0.8462 Intermediate Similarity NPC476579
0.8462 Intermediate Similarity NPC476568
0.8452 Intermediate Similarity NPC248642
0.8452 Intermediate Similarity NPC275132
0.8447 Intermediate Similarity NPC320104
0.8443 Intermediate Similarity NPC126284
0.8443 Intermediate Similarity NPC27887
0.8442 Intermediate Similarity NPC144863
0.8442 Intermediate Similarity NPC253883
0.8442 Intermediate Similarity NPC90844
0.8442 Intermediate Similarity NPC95075
0.8431 Intermediate Similarity NPC145304
0.843 Intermediate Similarity NPC24260
0.8415 Intermediate Similarity NPC311991
0.8415 Intermediate Similarity NPC474708
0.8415 Intermediate Similarity NPC152212
0.8408 Intermediate Similarity NPC223124
0.8405 Intermediate Similarity NPC190332
0.8405 Intermediate Similarity NPC181653
0.8402 Intermediate Similarity NPC156576
0.8395 Intermediate Similarity NPC247972
0.8393 Intermediate Similarity NPC32413
0.8393 Intermediate Similarity NPC474506
0.8385 Intermediate Similarity NPC24954
0.8383 Intermediate Similarity NPC23219
0.8365 Intermediate Similarity NPC126519
0.8365 Intermediate Similarity NPC170503
0.8365 Intermediate Similarity NPC203784
0.8364 Intermediate Similarity NPC227060
0.8364 Intermediate Similarity NPC317439
0.8364 Intermediate Similarity NPC10908
0.8364 Intermediate Similarity NPC76682
0.8364 Intermediate Similarity NPC477640
0.8364 Intermediate Similarity NPC198498
0.8364 Intermediate Similarity NPC317145
0.8364 Intermediate Similarity NPC225597
0.8364 Intermediate Similarity NPC63646
0.8364 Intermediate Similarity NPC115284
0.8364 Intermediate Similarity NPC276890
0.8364 Intermediate Similarity NPC470739
0.8356 Intermediate Similarity NPC160193
0.8354 Intermediate Similarity NPC58766
0.8354 Intermediate Similarity NPC2295
0.8354 Intermediate Similarity NPC477564
0.8354 Intermediate Similarity NPC475686
0.8343 Intermediate Similarity NPC116284
0.8333 Intermediate Similarity NPC475393
0.8333 Intermediate Similarity NPC470879
0.8333 Intermediate Similarity NPC211296
0.8333 Intermediate Similarity NPC244554
0.8333 Intermediate Similarity NPC207824
0.8333 Intermediate Similarity NPC267408
0.8333 Intermediate Similarity NPC477258
0.8333 Intermediate Similarity NPC60538
0.8333 Intermediate Similarity NPC258695
0.8323 Intermediate Similarity NPC112575

  Chemically structural similarity: II. Similar Clinical/Approved Drugs

Similarity level is defined by Tanimoto coefficient (Tc) between two molecules.

●  The left chart: Distribution of similarity level between NPC146288 and all drugs/candidates.
●  The right table: Most similar clinical/approved drugs (Tc>=0.56 or Top200).

Similarity Score Similarity Level Drug ID Developmental Stage
0.9452 High Similarity NPD4584 Approved
0.9041 High Similarity NPD4664 Clinical (unspecified phase)
0.8654 High Similarity NPD7298 Approved
0.8609 High Similarity NPD5084 Clinical (unspecified phase)
0.8452 Intermediate Similarity NPD3641 Approved
0.8452 Intermediate Similarity NPD3640 Phase 3
0.8452 Intermediate Similarity NPD3639 Approved
0.8364 Intermediate Similarity NPD8251 Approved
0.8364 Intermediate Similarity NPD8252 Approved
0.8364 Intermediate Similarity NPD8099 Discontinued
0.8354 Intermediate Similarity NPD4773 Phase 2
0.8354 Intermediate Similarity NPD4772 Phase 2
0.8344 Intermediate Similarity NPD4017 Approved
0.8333 Intermediate Similarity NPD6029 Clinical (unspecified phase)
0.8333 Intermediate Similarity NPD6028 Clinical (unspecified phase)
0.8313 Intermediate Similarity NPD8156 Discontinued
0.8312 Intermediate Similarity NPD6783 Clinical (unspecified phase)
0.8171 Intermediate Similarity NPD6107 Approved
0.8101 Intermediate Similarity NPD6031 Approved
0.8101 Intermediate Similarity NPD6030 Approved
0.8037 Intermediate Similarity NPD6788 Approved
0.8025 Intermediate Similarity NPD3124 Discontinued
0.8024 Intermediate Similarity NPD4481 Phase 3
0.8023 Intermediate Similarity NPD8053 Approved
0.8023 Intermediate Similarity NPD8054 Approved
0.8012 Intermediate Similarity NPD4166 Phase 2
0.8 Intermediate Similarity NPD7201 Clinical (unspecified phase)
0.7987 Intermediate Similarity NPD2669 Clinical (unspecified phase)
0.7933 Intermediate Similarity NPD5718 Phase 2
0.7904 Intermediate Similarity NPD3051 Approved
0.7882 Intermediate Similarity NPD5312 Approved
0.7882 Intermediate Similarity NPD5313 Approved
0.7881 Intermediate Similarity NPD554 Clinical (unspecified phase)
0.7861 Intermediate Similarity NPD7280 Phase 3
0.7861 Intermediate Similarity NPD7281 Phase 3
0.7857 Intermediate Similarity NPD2969 Approved
0.7857 Intermediate Similarity NPD2970 Approved
0.7833 Intermediate Similarity NPD4420 Approved
0.7811 Intermediate Similarity NPD2489 Approved
0.7811 Intermediate Similarity NPD2898 Approved
0.7811 Intermediate Similarity NPD27 Approved
0.7798 Intermediate Similarity NPD4010 Discontinued
0.7792 Intermediate Similarity NPD6895 Approved
0.7792 Intermediate Similarity NPD6896 Approved
0.7785 Intermediate Similarity NPD5241 Discontinued
0.7771 Intermediate Similarity NPD7832 Clinical (unspecified phase)
0.7771 Intermediate Similarity NPD7833 Phase 2
0.7771 Intermediate Similarity NPD7831 Phase 2
0.776 Intermediate Similarity NPD5005 Approved
0.776 Intermediate Similarity NPD5006 Approved
0.775 Intermediate Similarity NPD1754 Clinical (unspecified phase)
0.7738 Intermediate Similarity NPD7802 Discontinued
0.7697 Intermediate Similarity NPD6818 Clinical (unspecified phase)
0.7692 Intermediate Similarity NPD6071 Discontinued
0.7688 Intermediate Similarity NPD7598 Phase 2
0.7682 Intermediate Similarity NPD5752 Clinical (unspecified phase)
0.7661 Intermediate Similarity NPD5602 Clinical (unspecified phase)
0.7651 Intermediate Similarity NPD2563 Approved
0.7651 Intermediate Similarity NPD2560 Approved
0.7651 Intermediate Similarity NPD5977 Approved
0.7651 Intermediate Similarity NPD5978 Approved
0.7647 Intermediate Similarity NPD4474 Approved
0.7647 Intermediate Similarity NPD4475 Approved
0.7613 Intermediate Similarity NPD2492 Phase 1
0.7597 Intermediate Similarity NPD3109 Approved
0.7597 Intermediate Similarity NPD3110 Approved
0.7595 Intermediate Similarity NPD7045 Clinical (unspecified phase)
0.7593 Intermediate Similarity NPD3647 Clinical (unspecified phase)
0.759 Intermediate Similarity NPD2977 Approved
0.759 Intermediate Similarity NPD2978 Approved
0.7586 Intermediate Similarity NPD6297 Approved
0.7579 Intermediate Similarity NPD3815 Phase 1
0.7579 Intermediate Similarity NPD3816 Phase 1
0.7578 Intermediate Similarity NPD2420 Approved
0.7578 Intermediate Similarity NPD2421 Approved
0.7561 Intermediate Similarity NPD7261 Clinical (unspecified phase)
0.756 Intermediate Similarity NPD5604 Discontinued
0.7547 Intermediate Similarity NPD5177 Phase 3
0.7546 Intermediate Similarity NPD4727 Phase 1
0.7531 Intermediate Similarity NPD1424 Approved
0.7527 Intermediate Similarity NPD7667 Clinical (unspecified phase)
0.75 Intermediate Similarity NPD5754 Discontinued
0.75 Intermediate Similarity NPD6748 Discontinued
0.75 Intermediate Similarity NPD8095 Phase 1
0.747 Intermediate Similarity NPD7110 Phase 1
0.747 Intermediate Similarity NPD7109 Clinical (unspecified phase)
0.7468 Intermediate Similarity NPD1632 Clinical (unspecified phase)
0.7458 Intermediate Similarity NPD7310 Approved
0.7458 Intermediate Similarity NPD2968 Approved
0.7458 Intermediate Similarity NPD7312 Approved
0.7458 Intermediate Similarity NPD2971 Approved
0.7458 Intermediate Similarity NPD7311 Approved
0.7458 Intermediate Similarity NPD7313 Approved
0.7453 Intermediate Similarity NPD5307 Clinical (unspecified phase)
0.7425 Intermediate Similarity NPD7945 Clinical (unspecified phase)
0.7416 Intermediate Similarity NPD6851 Approved
0.7416 Intermediate Similarity NPD7309 Approved
0.7416 Intermediate Similarity NPD6618 Phase 2
0.7416 Intermediate Similarity NPD6853 Approved
0.7407 Intermediate Similarity NPD7124 Phase 2
0.7391 Intermediate Similarity NPD3977 Clinical (unspecified phase)
0.7389 Intermediate Similarity NPD7906 Approved
0.7374 Intermediate Similarity NPD5087 Clinical (unspecified phase)
0.736 Intermediate Similarity NPD4578 Approved
0.736 Intermediate Similarity NPD4577 Approved
0.7353 Intermediate Similarity NPD4055 Discovery
0.7341 Intermediate Similarity NPD6688 Approved
0.7341 Intermediate Similarity NPD6687 Approved
0.7333 Intermediate Similarity NPD4663 Approved
0.733 Intermediate Similarity NPD3885 Approved
0.7329 Intermediate Similarity NPD4237 Approved
0.7329 Intermediate Similarity NPD4236 Phase 3
0.731 Intermediate Similarity NPD7400 Phase 3
0.7303 Intermediate Similarity NPD7258 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD2422 Clinical (unspecified phase)
0.7301 Intermediate Similarity NPD3845 Phase 1
0.7296 Intermediate Similarity NPD4108 Discontinued
0.7293 Intermediate Similarity NPD7291 Discontinued
0.7293 Intermediate Similarity NPD3349 Phase 2
0.7289 Intermediate Similarity NPD4210 Discontinued
0.7284 Intermediate Similarity NPD6658 Clinical (unspecified phase)
0.7273 Intermediate Similarity NPD5457 Discontinued
0.7263 Intermediate Similarity NPD3534 Clinical (unspecified phase)
0.7255 Intermediate Similarity NPD4098 Discontinued
0.7243 Intermediate Similarity NPD5582 Discontinued
0.7229 Intermediate Similarity NPD5976 Discontinued
0.7229 Intermediate Similarity NPD6662 Clinical (unspecified phase)
0.7222 Intermediate Similarity NPD4162 Approved
0.7219 Intermediate Similarity NPD3383 Approved
0.7219 Intermediate Similarity NPD3382 Approved
0.7219 Intermediate Similarity NPD3384 Approved
0.7213 Intermediate Similarity NPD2488 Approved
0.7213 Intermediate Similarity NPD2490 Approved
0.7208 Intermediate Similarity NPD7247 Discontinued
0.7207 Intermediate Similarity NPD8453 Clinical (unspecified phase)
0.7202 Intermediate Similarity NPD6875 Approved
0.7202 Intermediate Similarity NPD6876 Approved
0.72 Intermediate Similarity NPD2668 Approved
0.72 Intermediate Similarity NPD2667 Approved
0.7193 Intermediate Similarity NPD4581 Clinical (unspecified phase)
0.7192 Intermediate Similarity NPD5283 Phase 1
0.7171 Intermediate Similarity NPD2232 Approved
0.7171 Intermediate Similarity NPD2233 Approved
0.7171 Intermediate Similarity NPD2230 Approved
0.717 Intermediate Similarity NPD4579 Clinical (unspecified phase)
0.7169 Intermediate Similarity NPD6090 Discontinued
0.7168 Intermediate Similarity NPD5677 Discontinued
0.7167 Intermediate Similarity NPD5917 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD3408 Clinical (unspecified phase)
0.7158 Intermediate Similarity NPD7235 Clinical (unspecified phase)
0.7134 Intermediate Similarity NPD6812 Clinical (unspecified phase)
0.7125 Intermediate Similarity NPD7119 Phase 2
0.712 Intermediate Similarity NPD5525 Clinical (unspecified phase)
0.7119 Intermediate Similarity NPD4498 Clinical (unspecified phase)
0.7117 Intermediate Similarity NPD3060 Approved
0.7111 Intermediate Similarity NPD7132 Clinical (unspecified phase)
0.7105 Intermediate Similarity NPD3705 Approved
0.7102 Intermediate Similarity NPD6365 Clinical (unspecified phase)
0.7098 Intermediate Similarity NPD4859 Phase 1
0.7097 Intermediate Similarity NPD7905 Discontinued
0.7097 Intermediate Similarity NPD6493 Phase 3
0.7089 Intermediate Similarity NPD2674 Phase 3
0.7085 Intermediate Similarity NPD3763 Approved
0.7083 Intermediate Similarity NPD7607 Clinical (unspecified phase)
0.7081 Intermediate Similarity NPD1753 Discontinued
0.7076 Intermediate Similarity NPD5772 Approved
0.7076 Intermediate Similarity NPD5773 Approved
0.7073 Intermediate Similarity NPD6331 Phase 2
0.7069 Intermediate Similarity NPD6037 Discontinued
0.7063 Intermediate Similarity NPD2653 Approved
0.7055 Intermediate Similarity NPD1372 Clinical (unspecified phase)
0.7052 Intermediate Similarity NPD7975 Clinical (unspecified phase)
0.7044 Intermediate Similarity NPD2238 Phase 2
0.7041 Intermediate Similarity NPD4005 Discontinued
0.7039 Intermediate Similarity NPD3920 Phase 2
0.7035 Intermediate Similarity NPD2358 Clinical (unspecified phase)
0.7033 Intermediate Similarity NPD7090 Clinical (unspecified phase)
0.703 Intermediate Similarity NPD5160 Discontinued
0.703 Intermediate Similarity NPD3692 Discontinued
0.7025 Intermediate Similarity NPD5111 Phase 2
0.7025 Intermediate Similarity NPD3144 Approved
0.7025 Intermediate Similarity NPD5110 Phase 2
0.7025 Intermediate Similarity NPD3145 Approved
0.7025 Intermediate Similarity NPD5109 Approved
0.7024 Intermediate Similarity NPD2122 Discontinued
0.7024 Intermediate Similarity NPD1914 Approved
0.7022 Intermediate Similarity NPD5708 Clinical (unspecified phase)
0.7021 Intermediate Similarity NPD2975 Approved
0.7021 Intermediate Similarity NPD7034 Discontinued
0.7021 Intermediate Similarity NPD2974 Approved
0.7021 Intermediate Similarity NPD2973 Approved
0.7019 Intermediate Similarity NPD2200 Suspended
0.7018 Intermediate Similarity NPD5720 Discontinued
0.7013 Intermediate Similarity NPD1421 Approved
0.7013 Intermediate Similarity NPD1420 Approved
0.7 Intermediate Similarity NPD1337 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD4580 Approved
0.7 Intermediate Similarity NPD6996 Clinical (unspecified phase)
0.7 Intermediate Similarity NPD8318 Clinical (unspecified phase)
0.6994 Remote Similarity NPD3656 Approved

  Bioactivity similarity: Similar Natural Products in NPASS

Bioactivity similarity was calculated based on bioactivity descriptors of compounds. The bioactivity descriptors were calculated by a recently developed AI algorithm Chemical Checker (CC) [Nature Biotechnology, 38:1087–1096, 2020; Nature Communications, 12:3932, 2021], which evaluated bioactivity similarities at five levels:
A: chemistry similarity;
B: biological targets similarity;
C: networks similarity;
D: cell-based bioactivity similarity;
E: similarity based on clinical data.

Those 5 categories of CC bioactivity descriptors were calculated and then subjected to manifold projection using UMAP algorithm, to project all NPs on a 2-Dimensional space. The current NP was highlighted with a small circle in the 2-D map. Below figures: left-to-right, A-to-E.

A: chemistry similarity
B: biological targets similarity
C: networks similarity
D: cell-based bioactivity similarity
E: similarity based on clinical data